Author | F. Puente


Relapsed Follicular Lymphoma: Response to a Fludarabine/Mitoxantrone Regimen and the Monoclonal Anti-CD20 Antibody Rituximab

March 01, 2001

ByP. Giraldo|F. Pelegrín|L. Palomera|V. Recasens|M. J. Nájera|F. Puente|L. Perdiguer|D. Rubio-Félix

Our objective was to determine the efficacy of a fludarabine (Fludara)/mitoxantrone (Novantrone) regimen combined with the monoclonal anti-CD20 antibody rituximab (Rituxan) to induce clinical and molecular remissions in patients with relapsed